Navigation Links
Emisphere in Medical News

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Co. Ltd. (Tokyo Stock Exchange: 4523) Mylan, Inc. (NYSE: MYL ) Metabolic-Endocrine Disorders Index (HHM) Drop Depomed Inc. (Nasdaq: DEPO ) emisphere Technologies Inc. (Nasdaq: EMIS ) Flamel Technologies SA ADS (Nasdaq: FLML ) Hospira Inc. (NYSE: HSP ) Human Genome Sciences, Inc. (Nasdaq: ...

Emisphere Names Adam Friedman Associates IR Agency of Record

...A) as its agency of record for Investor Relations. emisphere is a biopharmaceutical company that focuses on a u... collateral materials and roadshows. "As a 'new' emisphere continues to emerge, it is vital that we maintain ...alize enhanced stock valuation over time." About emisphere Technologies, Inc. ...
Emisphere in Medical Technology

Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology

CEDAR KNOLLS, N.J., April 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) announced today that additional preclinical in vivo studies using dogs further demonstrate that its proprietary eligen(R) technology enhances the absorption of oral B12. These data confirm in a...

Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment

... and Chief Executive Officer of Emisphere. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation

...roprietary, synthetic chemical compounds, known as emisphere delivery agents, sometimes called carriers. Emisph...-785-424-1053 (International). ABOUT EMISPHERE emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations

...isk's proprietary GLP-1 receptor agonists. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)

...n, disabling fractures, and lost mobility. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

...ent for diseases associated with accelerated bone loss. The lead compound in this investigational pipeline, G4544, was developed in collaboration with emisphere Technologies, Inc. (Nasdaq: EMIS ) and has completed its initial Phase 1 dose-ranging study. Results of this study will be presented at the Annual Me...

Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses

... B12 that can deliver therapeutic levels." ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology

...N is 871428. A slide deck will be available on the emisphere web site at the time of the call. About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...

Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases

...edings of the upcoming annual meeting of the American Society of Hematology. G4544 is a new tablet formulation using delivery technology developed by emisphere Technologies, Inc. that enables oral absorption of the active ingredient contained in Ganite(R) (gallium nitrate injection). Ganite(R) is marketed by ...

Genta Incorporated Announces Third Quarter 2007 Financial Results

... . Initial clinical trial for G4544 opens: a new oral drug for bone disease G4544 is a new tablet formulation using delivery technology developed by emisphere Technologies, Inc. that enables oral absorption of the active ingredient contained in Ganite. This compound is a highly potent inhibitor of bone loss....
Emisphere in Biological News

New technology may prevent vitamin B12 deficient seniors and vegetarians from needing injections

...n B12 is a perfect example of the successful application of our eligen technology," said Cristina Castelli, Ph. D., AAPS expert and lead researcher at emisphere Technologies, Inc. "Our current studies have shown our oral solid formulation brings vitamin B12 absorption to a range of 7-30% without the discomfort...
Emisphere in Biological Technology

Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

Former Organon Exec Will Help Drive Company's Commercialization of Eligen(R) Technology CEDAR KNOLLS, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) has announced that Nicholas J. Hart has joined the company as Vice President of Strategy and Development...

Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript

CEDAR KNOLLS, N.J., May 16 /PRNewswire-FirstCall/ -- Highlighting the company's expectations for the future as well as its current product pipeline, Michael V. Novinski, President and CEO of Emisphere Technologies, Inc. (Nasdaq: EMIS ), was featured in an extensive interview published recentl...

BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals

...k at Eastview campus in Tarrytown, New York, which was previously leased to emisphere Technologies, Inc. Commenting on Regeneron's lease expansion, Alan D. ...ion with the Regeneron expansion, BioMed terminated its previous lease with emisphere Technologies, Inc. which was previously scheduled to expire in 2012. BioMe...

Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment

...ibute to solving this problem, and also shows that emisphere is a valuable partner in drug development." About emisphere Technologies, Inc. emisphere is a biopharmaceutical company that focuses on a u...

Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

...ults for the first quarter ended March 31, 2008. emisphere will host a conference call to discuss first quart...s and Canada) or 1-402-220-1346 (International). emisphere will conduct its Annual Stockholders Meeting on Th... 10:00 AM EDT. FIRST QUARTER FINANCIAL RESULTS emisphere reported a net loss of $3.9 million, or $0.13 per ...

Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results

...Canada) or 1-402-220-1346 (International). About emisphere Technologies, Inc. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements

...o NASDAQ's corporate governance standards. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008

... The meeting will begin at 10:00 a.m. EDT. ABOUT emisphere TECHNOLOGIES, INC. emisphere Technologies, Inc. is a biopharmaceutical company ...ase and oral statements made by representatives of emisphere relating to matters that are not historical facts ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...sai Co. Ltd. (Tokyo Stock Exchange: 4523) Mylan, Inc. (NYSE: MYL ) Metabolic-Endocrine Disorders Index (HHM) Drop Depomed Inc. (Nasdaq: DEPO ) emisphere Technologies Inc. (Nasdaq: EMIS ) Flamel Technologies SA ADS (Nasdaq: FLML ) Hospira Inc. (NYSE: HSP ) Human Genome Sciences, Inc. (Nasdaq: HGS...

Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results

...fourth quarter and year ended December 31, 2007. emisphere will host a conference call to discuss fourth quar...N is 3149335. FOURTH QUARTER FINANCIAL RESULTS emisphere reported a net loss of $3.9 million, or $0.13 per ... Executive Officer. YEAR END FINANCIAL RESULTS emisphere reported a net loss of $16.9 million, or $0.58 per...
Other Tags
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... by Cesar A. Arias, M.D., Ph.D., at The University ... identified a new superbug that caused a bloodstream infection ... April 17 issue of The New England Journal ... of a class of highly-resistant bacteria known as methicillin-resistant ... major cause of hospital and community-associated infections. The superbug ...
(Date:4/17/2014)... Massage therapy improves general blood flow and alleviates ... by researchers at the University of Illinois at ... of print in the Archives of Physical ... improved vascular function in people who had not ... regardless of their level of physical activity. , ...
(Date:4/17/2014)... adrenaline after they suffer a cardiac arrest outside of ... long-term, according to new research conducted at St. Michael,s ... a cardiac arrest get adrenaline, which has been the ... Dr. Steve Lin, an emergency physician and trauma team ... treatment, long-term survival rates of patients who suffer a ...
(Date:4/16/2014)... STANFORD, Calif. Consider the marvel of the embryo. It ... and function as they multiply to become the cells of ... of the body. , Now, in a feat of reverse ... complex genetic coding that allows embryonic cells to proliferate and ...
Breaking Medicine News(10 mins):Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
(Date:4/17/2014)... Double-stapled peptide inhibits RSV infection , Respiratory ... lower respiratory tract infections, generating life-threating illness in ... preventive therapies are limited. RSV enters host cells ... a six-helix fusogenic bundle. Small interfering peptides that ... however, these peptides are highly susceptible to degradation. ...
(Date:4/17/2014)... 16, 2014. Kessler Foundation has been named awardee ... the Department of Defense Spinal Cord Injury Research ... for the randomized, double-blinded, controlled, multi-site clinical trial, ... muscle strength after spinal cord injury. Dr. Forrest ... Research at Kessler Foundation. Two additional sites will ...
(Date:4/17/2014)... developed at Sandia National Laboratories and recently licensed to ... cheaper. , Bacillus anthracis , the bacteria ... over the world and can cause serious, and often ... can survive in harsh conditions for decades. In humans, ... skin contact, inhalation of spores or eating contaminated meat. ...
Breaking Biology News(10 mins):JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
Other Contents